Long-Term Cost-Effectiveness the Dexcom G6 Real-Time Continuous Glucose Monitoring System Compared with Self-Monitoring of Blood Glucose in People with Type 1 Diabetes in France.

Roze, Stéphane; Isitt, John J; Smith-Palmer, Jayne; Lynch, Peter; Klinkenbijl, Brigitte; Zammit, Gerald; Benhamou, Pierre-Yves

Roze, Stéphane; Isitt, John J; Smith-Palmer, Jayne; Lynch, Peter; Klinkenbijl, Brigitte; Zammit, Gerald; Benhamou, Pierre-Yves.

Afiliação

Roze S; Vyoo Agency, Lyon, France.
Isitt JJ; Vyoo Agency, Lyon, France.
Smith-Palmer J; Ossian Health Economics and Communications, Basel, Switzerland. smith-palmer@ossianconsulting.com.
Lynch P; Dexcom, San Diego, CA, USA.
Klinkenbijl B; Dexcom, Essertines-sur-Rolle, Switzerland.
Zammit G; Dexcom, Reading, UK.
Benhamou PY; Department of Endocrinology, Grenoble Alpes University Hospital, Grenoble, France.

Diabetes Ther ; 12(1): 235-246, 2021 Jan.

Article em En | MEDLINE | ID: mdl-33165838

Palavras-chave

Cost-effectiveness; France; Real-time continuous glucose monitoring; Type 1 diabetes

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Temas: ECOS / Financiamentos_gastos Bases de dados: MEDLINE Tipo de estudo: Clinical_trials / Health_economic_evaluation Aspecto: Patient_preference Idioma: En Revista: Diabetes Ther Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google